Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.50 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2547694 | 1.00 | NPSR1 (0.50) | NPSR1GLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL6274167 | 0.85 | — | — | |
| SCHEMBL6274170 | 0.85 | — | — | |
| SCHEMBL598483 | 0.84 | NPSR1 (0.48) | NPSR1GLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL1321694 | 0.84 | NPSR1 (0.65) | NPSR1GLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL5667523 | 0.84 | NPSR1 (0.65) | NPSR1GLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL7772643 | 0.84 | NPSR1 (0.48) | NPSR1GLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL554289 | 0.84 | NPSR1 (0.48) | NPSR1GLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL5612231 | 0.84 | NPSR1 (0.65) | NPSR1GLO1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL9364371 | 0.82 | NPSR1 (0.47) | NPSR1GLO1ALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115943059-A | Three-dimensional printing | 惠普发展公司，有限责任合伙企业 | 2023-04-07 | — | — | CN | disclosed |
| CN-109369839-B | Self-crosslinking vinyl chloride copolymer emulsion and preparation method thereof | 无锡洪汇新材料科技股份有限公司 | 2020-12-29 | — | — | CN | disclosed |
| CN-110869851-A | Underlayer coating forming composition, pattern forming method, and copolymer for forming underlayer coating forming pattern | 王子控股株式会社 | 2020-03-06 | — | — | CN | disclosed |
| US-8217204-B2 | Catalyst for asymmetric hydrogenation | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-12-23 | — | — | US | disclosed |
| US-20030032736-A1 | Acrylic adhesive compositions containing ketonyl (meth)acrylate | KNEAFSEY BRENDAN J (IE) | 2003-02-13 | — | — | US | disclosed |
| WO-2001051576-A1 | ACRYLIC ADHESIVE COMPOSITIONS CONTAINING KETONYL (METH)ACRYLATE | LOCTITE (R & D) LIMITED (IE) | 2001-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | H1-0, H1-5, ADH5 | NPSR1 2526/4885GLO1 525/4885ALDH1A1 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.